Phase I/II trial of BPX 201 + rimiducid in patients with castrate-resistant metastatic prostate cancer

Trial Profile

Phase I/II trial of BPX 201 + rimiducid in patients with castrate-resistant metastatic prostate cancer

Planning
Phase of Trial: Phase I/II

Latest Information Update: 17 Mar 2015

At a glance

  • Drugs BPX 201 (Primary) ; Rimiducid
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Bellicum Pharmaceuticals
  • Most Recent Events

    • 17 Mar 2015 New trial record
    • 11 Mar 2015 This trial is expected to be initiated by the end of 2015, according to a Bellicum Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top